Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
2.134
-0.027 (-1.23%)
Nov 21, 2024, 3:17 PM EST - Market open
Akoya Biosciences Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$4.40
Upside
+106.23%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $4 → $3 | Buy | Reiterates | $4 → $3 | +40.61% | Nov 19, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy → Hold Downgrades $7 → $5 | Strong Buy → Hold | Downgrades | $7 → $5 | +134.36% | Nov 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $6 → $3.5 | Strong Buy | Maintains | $6 → $3.5 | +64.05% | Nov 15, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $4 | Buy | Maintains | $6 → $4 | +87.49% | Aug 13, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $4 → $3 | Buy → Hold | Downgrades | $4 → $3 | +40.61% | Aug 6, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 6, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $7.5 → $7 | Strong Buy | Maintains | $7.5 → $7 | +228.10% | Aug 6, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 6, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $8 → $4 | Buy | Maintains | $8 → $4 | +87.49% | Jun 3, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +181.23% | May 14, 2024 |
| BTIG | BTIG | Strong Buy Maintains $9 → $6 | Strong Buy | Maintains | $9 → $6 | +181.23% | May 14, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +368.71% | Mar 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +368.71% | Mar 5, 2024 |
| UBS | UBS | Strong Buy Maintains $7 → $7.5 | Strong Buy | Maintains | $7 → $7.5 | +251.54% | Mar 5, 2024 |
| Guggenheim | Guggenheim | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Dec 14, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $8 | Buy | Maintains | $11 → $8 | +274.97% | Nov 13, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.